|
|
|
Volumn 165, Issue 6, 2001, Pages 791-797
|
|
New advances in the management of acute coronary syndromes: 2. Fibrinolytic therapy for acute ST-segment elevation myocardial infarction
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ALTEPLASE;
ANTICOAGULANT AGENT;
ATROPINE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BLOOD CLOTTING FACTOR;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENOXAPARIN;
FIBRIN;
FIBRINOGEN;
FIBRINOGEN RECEPTOR;
FIBRINOLYTIC AGENT;
GLYCERYL TRINITRATE;
HEPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
NEUTRALIZING ANTIBODY;
PLASMIN;
PLASMINOGEN;
RETEPLASE;
STREPTOKINASE;
TENECTEPLASE;
THROMBOCYTE SLOWING FACTOR;
TISSUE PLASMINOGEN ACTIVATOR;
BLEEDING;
BLOOD CLOT LYSIS;
BRADYCARDIA;
BRAIN HEMORRHAGE;
CLINICAL TRIAL;
CORONARY STENT;
DOSE TIME EFFECT RELATION;
DRUG EFFICACY;
DRUG INFUSION;
ELECTROCARDIOGRAPHY;
FIBRINOLYTIC THERAPY;
HEART MUSCLE ISCHEMIA;
HEART MUSCLE REPERFUSION;
HEART REINFARCTION;
HUMAN;
HYPOTENSION;
INTRAVENOUS ADMINISTRATION;
META ANALYSIS;
MONOTHERAPY;
MORTALITY;
PATIENT SELECTION;
RECOMBINANT DNA TECHNOLOGY;
RESUSCITATION;
REVIEW;
ST SEGMENT ELEVATION;
SYMPTOMATOLOGY;
TREATMENT CONTRAINDICATION;
TREATMENT FAILURE;
TREATMENT INDICATION;
VASCULAR ENDOTHELIUM;
|
|
EID: 0034814162
PISSN: 08203946
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (27)
|
